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van Duijvenboden S, Hanson B, Child N, Orini M, Rinaldi CA,
Gill JS, Taggart P. Effect of autonomic blocking agents on the respira-
tory-related oscillations of ventricular action potential duration in hu-
mans. Am J Physiol Heart Circ Physiol 309: H2108–H2117, 2015. First
published October 16, 2015; doi:10.1152/ajpheart.00560.2015.—Ven-
tricular action potential duration (APD) is an important component of
many physiological functions including arrhythmogenesis. APD os-
cillations have recently been reported in humans at the respiratory
frequency. This study investigates the contribution of the autonomic
nervous system to these oscillations. In 10 patients undergoing treat-
ment for supraventricular arrhythmias, activation recovery intervals
(ARI; a conventional surrogate for APD) were measured from mul-
tiple left and right ventricular (RV) endocardial sites, together with
femoral artery pressure. Respiration was voluntarily regulated and
heart rate clamped by RV pacing. Sympathetic and parasympathetic
blockade was achieved using intravenous metoprolol and atropine,
respectively. Metroprolol reduced the rate of pressure development
(maximal change in pressure over time): 1,271 ( 646) vs. 930 (
433) mmHg/s; P  0.01. Systolic blood pressure (SBP) showed a
trend to decrease after metoprolol, 133 ( 21) vs. 128 ( 25) mmHg;
P  0.06, and atropine infusion, 122 ( 26) mmHg; P  0.05. ARI
and SBP exhibited significant cyclical variations (P  0.05) with
respiration in all subjects with peak-to-peak amplitudes ranging be-
tween 0.7 and 17.0 mmHg and 1 and 16 ms, respectively. Infusion of
metoprolol reduced the mean peak-to-peak amplitude [ARI, 6.2 (
1.4) vs. 4.4 ( 1.0) ms, P  0.008; SBP, 8.4 ( 1.6) vs. 6.2 ( 2.0)
mmHg, P 0.002]. The addition of atropine had no significant effect.
ARI, SBP, and respiration showed significant coupling (P  0.05) at
the breathing frequency in all subjects. Directed coherence from
respiration to ARI was high and reduced after metoprolol infusion
[0.70 ( 0.17) vs. 0.50 ( 0.23); P  0.05]. These results suggest a
role of respiration in modulating the electrophysiology of ventricular
myocardium in humans, which is partly, but not totally, mediated by
-adrenergic mechanisms.
respiration; cardiac electrophysiology; -adrenergic blockade; para-
sympathetic blockade
NEW & NOTEWORTHY
Ventricular action potential repolarization is critical to elec-
trical stability and arrhythmogenesis. Oscillations at the respi-
ratory frequency were investigated in humans by combining
endocardial electrophysiological recordings, controlled respi-
ration with adrenergic blocking agents. Results are consistent
with a partial role of the sympathetic nervous system combined
with additional mechanisms, possibly involving mechano-elec-
tric feedback.
DYNAMIC CHANGES IN ACTION potential duration (APD) are a
critical component of many fundamental electrophysiological
properties. Alterations of the normal time course of APD are a
key factor in arrhythmogenesis (25, 34, 51, 54). Elucidation of
the multiple mechanisms that underlie modulation of ventric-
ular repolarization is, therefore, an important challenge. Ven-
tricular APD has recently been observed to exhibit oscillations
related to respiration in humans with healthy ventricles (18,
19). The mechanism is as yet undetermined.
Several considerations suggest the possibility of a role of the
autonomic nervous system in respiratory-related ventricular
APD oscillations. Heart rate is well known to exhibit cyclical
variation with the respiratory cycle, known as respiratory sinus
arrhythmia, usually attributed to waxing and waning of auto-
nomic input to the sinus node (1, 2, 4, 9, 31). Ventricular
myocardium is now known to receive substantial vagal as well
as sympathetic innervation (7), raising the possibility of cycli-
cal autonomic influence in the ventricle. Both sympathetic and
vagal stimulation may modulate ventricular APD (30, 32,
35, 43, 50, 55). Respiration is known to gate the timing of
autonomic motor neurone firing such that inspiration is
associated with an increase in sympathetic and decrease in
parasympathetic nerve activity (8, 16, 28), again suggesting
the possibility of respiratory-related autonomic modulation
of ventricular APD. In the present study, therefore, we
sought to examine the contribution of autonomic nervous
system to respiratory-related ventricular APD oscillations in
humans in vivo.
We have collected a unique database including activation
recovery intervals (ARIs) measured from unipolar electro-
grams as a conventional surrogate for ventricular APD (5, 21,
33, 40, 53) from multiple right and left ventricular endocardial
sites, femoral arterial blood pressure, and respiration (chest
movement), in humans with healthy ventricles. Respiratory
rate was controlled and heart rate clamped by ventricular
pacing to avoid confounding effects due to the cycle length
dependency of APD. Autonomic blocking agents were admin-
istered intravenously to selectively study the contribution of
sympathetic and parasympathetic modulation of respiratory-
related oscillations of APD. We hypothesized that autonomic
blocking agents would reduce the amplitude of the oscillations
if autonomic input is indeed involved. To further investigate
the mechanisms underlying respiratory-related APD oscilla-
tions, multivariate frequency domain analysis was used to
characterize the causal interactions between APD, respiration,
and blood pressure. In addition, phase analysis was imple-
mented to investigate the oscillatory behavior of APD in the
left and right ventricle.
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METHODS
Ethical approval. The study was approved by the ethics committee
of Guy’s and Thomas= Hospitals and conformed to the standards set
by the Declaration of Helsinki (latest revision: 59th World Medical
Association General Assembly). All patients gave written, informed
consent.
Subjects. Studies were performed in 10 patients (8 males, 2 fe-
males, aged 48–68, median 54) during the course of routine clinical
radiofrequency ablation procedures for atrial fibrillation. Four patients
had paroxysmal atrial fibrillation, and six patients established atrial
fibrillation. All patients had normal ventricular function and were
otherwise apparently healthy. No subject was known to have ventric-
ular scar or disordered conduction due to bundle branch abnormality.
The studies were conducted in the cardiac catheterization suite at St
Thomas= Hospital before the routine clinical procedure in the unse-
dated state as described previously (20, 45). Cardio-active medica-
tions were discontinued for 5 days before the study.
Measurements. Synchronous measurements were made of the un-
ipolar electrogram (UEG), femoral arterial blood pressure, and respi-
ration (chest movement).
UEGs were measured using two decapolar electrode catheters (St
Jude Medical, St. Paul, MN; 6F Livewire Steerable Catheter model
401915 with 2–5-2 mm spacing, 35 mm total span). One electrode
catheter was introduced from the femoral vein into the left ventricle
(via an atrial trans-septal approach) and positioned on the infero-
posterior endocardial wall in a base-apex orientation. The other
electrode catheter was introduced into the right ventricle and posi-
tioned on the anterior septal wall in a base-apex orientation. The
electrode arrays were positioned over the mid- and lower third of the
LV and RV endocardial wall. Both electrodes were referenced to a
large skin surface electrode (100  150 mm) on the abdomen at the
level of the naval such that distance to each individual electrode was
considered to be approximately equal. The position of the recording
and pacing electrodes are shown in Fig. 1A. Cine imaging fluoroscopy
was used to verify secure positioning of the catheters throughout the
cardiac and respiratory cycles. This has previously been established in
detail for catheters in these positions (19).
Arterial blood pressure was measured from a femoral artery with a
continuous-flush pressure transducer system (Tru-Wave PX600F; Ed-
wards Lifesciences, Irvine, CA). The subject’s breathing cycle was
monitored using a custom-constructed tension sensor fixed to a freely
expandable band placed around the chest/abdomen (adapted from a
RESPeRATE device; InterCure, New York, NY). The optimum lo-
cation for each subject was chosen as the site of maximum circum-
ferential strain during normal breathing.
Controlled respiration. To identify respiratory-related oscillations
of ARI and SBP, subjects were instructed to breathe at four fixed rates
(6, 9, 15, and 30 breaths/min) for 90 s each, in random order. This was
achieved with the aid of a large video monitor with a 19-inch diagonal
backlit screen mounted in easy line of site, on which was displayed a
computer-generated animated visual display representing lung vol-
ume, which cycled at the required breathing rate (implemented in
LabVIEW software; National Instruments, Austin, TX). Patients were
instructed to breath at the same rate as the movement of the cursor on
the screen. This was practiced before study commencement.
Protocol. Subjects were paced from the right ventricular apex using
a Biotronik (Berlin, Germany) stimulator (model UHS 3000) at 2
diastolic threshold and 2 ms pulse width, at a cycle length 20
beats/min faster than the intrinsic AF rate (median, 500 ms) to avoid
breakthrough intrinsic beats and counteract the expected increase in
intrinsic rate post atropine. A 2-min period of adaptation to the paced
cycle length was applied before starting the controlled breathing
Fig. 1. Electrophysiological measurements.
A: fluoroscopic image showing the position
of the two 10-pole recording catheters lo-
cated in the left ventricle (LV) and right
ventricle (RV). B: diagrammatic representa-
tion of the relationship between the unipolar
electrogram (UEG) and the intracellular ven-
tricular transmembrane potential (MP) dur-
ing an action potential (AP) showing that the
activation recovery interval (ARI) corre-
sponds to the action potential duration
(APD). C: example of ARI measurements of
the local UEG: times of activation are
marked with circles [minimal change in vol-
ume over time (dv/dtmin) of the QRS] and
repolarization with squares [maximal change
in volume over time (dv/dtmax) of the T
wave]. The interval between the 2 points is
the ARI, and values for each beat are shown
in milliseconds. Top: corresponding ARIs
plotted as function of time.
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protocol. First, a control period was established with the breathing
protocol performed in absence of any autonomic blocking agents. The
subject then received metoprolol at a dose sufficient to reduce the
intrinsic heart rate by 10 beats/min (iv; dose range, 2–10 mg), and
after 10 min for equilibration the breathing protocol was repeated.
Finally, the subjected was given atropine at a dose sufficient to
increase the intrinsic heart rate 10 beats/min faster than the starting
heart rate (iv; dose range, 600–1200 	g), and the breathing protocol
was once again repeated. During the experiment, electrograms, blood
pressure, and respiration were recorded synchronously.
Data analysis. Electrogram, blood pressure, and respiration record-
ings were sampled at 1,200 Hz (Ensite 3000; Endocardial Solutions)
and analyzed offline. Ventricular APDs at each recording site were
estimated from the UEG by measuring activation-recovery intervals
(ARIs) using the Wyatt method (53). This method has been validated
in theoretical, computational, and experimental studies (5, 21, 33, 40,
52). According to this method, activation is measured at the moment
of minimum dV/dt of the QRS complex of the UEG (5, 21, 33, 40, 53)
and repolarization at the moment of maximum dV/dt of the T-wave.
The relationship between APD and ARI is illustrated in Fig. 1B. In
this work, ARI was measured semi-automatically using a custom
algorithm written in MATLAB (Matlab Mathworks). Heuristic-based
screening was used to identify and discount any cases where the
T-wave was indistinct or corrupt.
Blood pressure recordings were analyzed for systolic blood pres-
sure (SBP) and the maximum rate of systolic pressure increase
(dP/dtmax) as a measure of myocardial contractility. To establish
evenly sampled series, any beats for which ARI or SBP measurement
could not be determined were replaced by linear interpolation between
the surrounding beats. If these surrogate beats constituted more than
10% of any series, the series was rejected.
Amplitude estimation of respiratory-related ARI and SBP
oscillations. The peak-to-peak amplitude of respiratory-related ARI
and SBP oscillations, hereinafter referred to as oscillations, was
estimated in the frequency domain using the Thomson’s multitaper
method with three Slepian tapers (48). This method was used because
of its robustness against noise. The power inside a breathing fre-
quency band, defined as the breathing frequency  10%, was mea-
sured and then converted to amplitude, which is half the peak-to-peak
amplitude. The ARI and SBP peak-to-peak amplitude was measured
in milliseconds and millimeters of mercury, respectively. The breath-
ing frequency was defined as the peak frequency in the power
spectrum of the respiratory signal.
Surrogate data analysis was used to establish a threshold to test
whether ARI oscillations were significant. Surrogate data series were
created by random permutations of the signal such that the amplitude
distribution remained intact, but the original (oscillatory) behavior
was destroyed (14). For each signal, 1,000 surrogate series were
generated and their corresponding spectra were computed. The thresh-
old function for significance was then determined for each frequency
bin as the upper 95th percentile of the surrogate distribution. ARI
oscillations were considered significant if the power at the breathing
frequency exceeded this threshold (P  0.05). Recording sites that
showed significant oscillations were selected for further analysis to
investigate the effect of autonomic drugs on the amplitude of the
oscillations.
Assessment of coupling and causality. Interactions between ARI,
SBP, and respiration (RESP) were characterized in the frequency
domain. Coupling was studied by means of coherence, which quan-
tifies the coupling strength between two signals as a function of
frequency. The coherence attains a value between 0, indicating ab-
sence of coupling, and 1, indicating full coupling. Directed coherence
was used to infer causality. Intuitively, the directed coherence repre-
sents the fraction of the power spectrum of a signal due to another
signal through direct or indirect pathways. This measure of causality
is grounded on the notion of Granger causality, stating that a process
is causal to another if the prediction of the second is improved by
incorporating the knowledge of the first (13). In this work, both
coherence and directed coherence are formulated in the framework of
an extended linear multivariate autoregressive (MVAR) model pro-
posed (11–13). This model takes into account both instantaneous and
lagged effects. The MVAR model is defined in Appendix A. Defini-
tions for coherence and directed coherence are provided in Appendix
B. The coefficients of the (multivariate) model were estimated using
the least-squares approach with a fixed model order of 10. The
resulting residuals of the trivariate model were tested for white noise
and independence.
Phase relationship between ARI oscillations in the left and right
ventricle. The phase relationship between left and right ventricular
ARI oscillations was studied by computing the mean phase lags for
the left and right ventricle recording sites. The lag was measured using
the Thomson’s multitaper cross-power spectrum computed to deter-
mine the phase at the breathing frequency using three tapers (23).
Recordings sites were included only if the signal exhibited signif-
icant amplitude and coherence at the breathing frequency. The rela-
tionship was then investigated by subtracting the mean phase from the
left and right ventricle.
Statistical analysis. For all subjects, mean values obtained for
dP/dtmax, SBP, amplitude of ARI, and SBP oscillations and the
(directed) coherence measures were averaged across the four respira-
tory rates. The effect of -blocker and atropine infusion was then
investigated by comparing control and -adrenergic blocking (BB)
values and BB and BB 
 atropine (AT) values using the two-tailed
paired Wilcoxon signed-rank test for statistical significance. Results
were considered significant at P  0.05.
RESULTS
The effect of autonomic blocking agents on blood pressure.
Figure 2 shows the effect of autonomic inhibitors on mean
blood pressure indexes. After administration of -adrenergic
blocking agents (metoprolol), the mean dP/dtmax was signifi-
cantly decreased [1,271 ( 646) vs. 930 ( 433) mmHg/s; P
0.01]. The mean SBP showed a tendency to decrease [baseline
133 ( 21) vs. metoprolol 128 ( 25) mmHg; P  0.06].
Addition of atropine was associated with a further significant
decrease of the mean dP/dtmax [930 ( 433) vs. 887 ( 436)
mmHg/s; P  0.05]. The mean SBP showed also a significant
decrease following the addition of atropine: 128 ( 25) vs. 122
( 26) mmHg; P  0.05.
Significant ARI and SBP oscillations were observed in all
subjects at all breathing frequencies in 61% and 92% of the
available recordings, respectively.
Two examples of ARI and SBP time series during paced
breathing at 6 and 15 breaths/min are shown in Fig. 3. In both
cases, ARI and SBP exhibit oscillatory behavior at the breath-
ing frequency.
The peak-to-peak amplitude of ARI oscillations was ranging
from 1.0 to 16.0 ms (left ventricle, 1.0–12.9 ms; right ventricle,
1.0–16.0 ms). The effect of autonomic blocking agents on the
mean peak-to-peak amplitude of respiratory-related ARI and
SBP oscillations is shown in Fig. 4. After administration of
-adrenergic blockers, the mean ARI peak-to-peak amplitude
decreased [6.6 ( 1.9) vs. 5.1 ( 2.4) ms; P  0.04; Fig. 4A].
The main effect was in the left ventricle, which showed a
significant reduction in peak-to-peak amplitude [6.2 ( 1.4) vs.
4.4 ( 1.0) ms; P  0.008; Fig. 4C]; in the right ventricle the
differences were not statistically significant [6.0 ( 2.2) vs. 4.9
( 2.7) ms; P  0.2; Fig. 4D]. Addition of atropine did not
result in any further changes of the ARI peak-to-peak ampli-
tude in both left and right ventricle.
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The peak-to-peak amplitude of SBP oscillations was ranging
from 0.7 to 17.0 mmHg. The mean peak-to-peak amplitude of
SBP oscillations showed a significant reduction following the
administration of -adrenergic blockers [8.4 ( 1.6) vs. 6.2 (
2.0) mmHg; P  0.002; Fig. 4B]. Subsequent addition of
atropine was not associated with any significant change [6.2 (
2.0) vs. 6.0 ( 2.4) mmHg; P  0.8].
In the LV the absolute ARI shows a tendency to increase at
the sites where ARIs were measured after administration of the
-blocker: control, 189 ms ( 25 ms), -blocker: 191 ms (
23 ms); this would be consistent with a reduced sympathetic
action on APD. Subsequent atropine administration shortened
ARI to 189 ( 20 ms), consistent with reduced parasympa-
thetic restraint on residual sympathetic tone resulting in APD
shortening.
Assessment of the interactions between ARI, SBP, and
respiration. Significant coherence (P  0.05) was detected
between ARI, SBP, and RESP, significant in all subjects. The
coherence was significant in 47% of the ARI signals. Figure 5
shows the mean coherences between ARI, SBP, and RESP. For
example, Fig. 5, left, shows that the mean coherence (coupling
strength) between ARI and RESP was strong, being 0.76 on a
scale of 0 to 1. The mean coherence was not affected by the
administration of autonomic inhibitors: ARIN RESP: 0.76 (
0.12) vs. 0.76 ( 0.12) vs. 0.75 ( 0.11); ARIN SBP: 0.71 (
0.11) vs. 0.71 ( 0.11) vs. 0.71 ( 0.11); SBPN RESP: 0.92
( 0.07) vs. 0.93 ( 0.07) vs. 0.93 ( 0.07) for control,
-blocker, and subsequent addition of atropine.
The results of the directed coherence analysis are presented
in Fig. 6. Figure 6A shows a graphical representation of the
(theoretical) possible interactive pathways between all pro-
cesses. The directed coherence describes the coherence accord-
ing to the direction of information transmission by measuring
the relative power contributions for all processes (ARI, SBP,
and respiration). Figure 6B shows the mean directed coherence
at the breathing frequency during control, -blocker, and
subsequent addition of atropine. Regarding the observed ARI
oscillation, during control, the directed coherence from respi-
ration to ARI (RESP ) ARI) was 0.70 ( 0.17), which means
that, at the breathing frequency, on average, 70% of the ARI
signal power could be explained by the respiratory signal.
In contrast, the directed coherence from SBP to ARI
(SBP ) ARI) was found to be marginal: SBP ) ARI: 0.07
( 0.06), indicating that the causal interaction from SBP to
ARI was weak.
High directed coherence was also found from respiration to
SBP (RESP ) SBP): 0.70 ( 0.17), whereas, as expected, the
directed coherence from ARI to SBP (ARI ) SBP) was low:
0.11 ( 0.05).
After administration of -adrenergic blockers, the directed
coherence from respiration to ARI was significantly reduced:
0.70 ( 0.17) vs. 0.50 ( 0.23), P  0.05. The directed
coherence from SBP to ARI showed a tendency to increase, but
remained very small: SBP ) ARI: 0.07 ( 0.06) vs. 0.12 (
0.07), P  0.06.
Regarding SBP oscillations, RESP ) SBP was not affected
by -blocker: 0.76 ( 0.17) vs. 0.75 ( 0.11), P  0.9. When
compared with RESP ) SBP, ARI ) SBP was very small
during both control and -blocker: 0.11 ( 0.05) and 0.06 (
0.06), respectively (P 0.05). Subsequent addition of atropine
did not result in any further changes of the directed coherences
(RESP ) ARI, SBP ) ARI, RESP ) SBP, and ARI ) SBP).
Investigation of the phase of left and right ventricular ARI
oscillations. The phase lag between respiration and ARI was
investigated for left and right ventricular recordings. During
control, on average, ARI oscillations in the LV lagged behind
RV oscillations: the mean relative phase difference was stati-
cally different from 0: 37 ( 46) dgr, P  0.05. The phase
difference did not change after administration of -blocker: 37
( 46) vs. 17 ( 45) dgr, P  0.6. However, the phase
difference was not statically significant from 0 anymore (P 
0.2). Addition of atropine was not associated with additional
changes: 17 ( 45) vs. 4 ( 78), P  0.7. Various phase
differences between RV and LV were observed between sub-
jects. Figure 7 shows an example of LV and RV ARI signals
that are approximately in phase (Fig. 7, left) and in anti-phase
(Fig. 7, right).
DISCUSSION
The duration of the ventricular action potential plays a
crucial role in maintaining electrical stability and in arrhyth-
mogenesis. Oscillations of APD in ventricular myocardium
have recently been shown to occur at the frequency of respi-
ration in human subjects (18, 19). To investigate the underlying
mechanism, we have used infusion of autonomic blocking
agents together with causal coherence analysis in subjects with
Fig. 2. Left: maximum rate of systolic pressure increase (dP/
dtmax) was significantly reduced after administration of the
-adrenergic blocking (BB) agent metoprolol. Subsequent ad-
dition of atropine (AT) was associated with a further small but
significant reduction. Right: systolic blood pressure (SBP)
showed no significant change following metoprolol but a sig-
nificant reduction following the addition of atropine. Error bars
indicate SE. C, control. *P  0.05; **P  0.01.
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healthy ventricles while recording a measure of ventricular
endocardial APD using catheter electrodes, SBP, and respira-
tion. The main findings were as follows: 1) we confirmed the
presence of oscillations in APD and SBP at each of four
controlled respiratory frequencies: 6, 9, 15, and 30 breaths/
min; 2) the -adrenergic blocking agent metoprolol resulted in
a decrease in the amplitude of APD oscillation; 3) IV admin-
istration of atropine following metoprolol was without effect
on LV or RV ARI oscillation amplitude; 4) coherence analysis
showed a significant linear coupling between respiration, APD,
and SBP at the breathing frequency; 5) analysis of the directed
coherence showed a high directed coherence from respiration
to APD and from respiration to SBP. -Adrenergic blockade
reduced the contribution of respiration to APD oscillations.
Methodological considerations. The unipolar signal re-
corded using the multipolar catheters as used here (St. Jude
Fig. 3. Respiratory-related ARI and SBP oscillations. A: example of ARI, SBP, and respiration (RESP) recordings for 0.1 Hz (6 breaths/min) breathing. Cyclical
variation was observed in both ARI and SBP at the breathing frequency. PSD, power spectral density. B: example of ARI, SBP, and RESP recordings for 0.25
Hz (15 breaths/min) breathing. Cyclical variation was observed in both ARI and SBP at the breathing frequency.
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Medical) has been extensively validated as a true representa-
tion of the local endocardial activity, and the derived ARI
measure as representative of the local APD (5, 40, 53), and has
been further validated in the context of the protocol used in the
present study (52). Respiratory frequency was well controlled
by the subjects, but we did not measure tidal volume, arterial
PCO2, and pH, which may affect APD. However, we measured
blood gasses and discussed this issue in a previous communi-
cation and concluded that any possible influence would be
small (19). In these studies autonomic blockade was not
complete. The dosage of metoprolol and atropine was titrated
on an individual patient basis to achieve a target change in
heart rate. This is a regime used in the clinical scenario where
complete blockade is avoided as the border between complete
blockade and overdose is narrow and unpredictable. As a
result, we cannot exclude the possibility that the level of
blockade may have affected our results. It is well known that
there is regional variation in parasympathetic innervation,
which is greatest at the base and decreases toward the apex, as
well as epicardial to endocardial differences. The electrode
arrays were located over the mid- and lower third of each
ventricle where stable recordings are best obtained. It is pos-
sible, therefore, that a response to atropine occurred in the
more basal regions, which we did not detect.
APD oscillations-mechanisms. We are at present unaware of
any reported observations on the effect of autonomic blocking
agents on the respiratory-related oscillations of ventricular
APD. Respiration physically alters membrane potentials of
sympathetic and parasympathetic preganglionic motoneurones
and thereby continuously modulates sympathetic neuronal and
vagal motorneurone activity over a wide range of frequencies
(8), both of which are known to modulate APD (30, 32, 35, 50,
55). Our results show a reduction in respiratory-related ARI
oscillation following administration of the -blocking agent
metoprolol with further reduction following atropine, suggest-
ing a role for autonomic nerve activity. One possibility is a
baroreflex-mediated effect on the autonomic modulation of
individual myocytes and hence APD in response to cyclic
variation in the hemodynamics during the respiratory cycle.
Although the exact relation between cardiopulmonary hemo-
dynamics and right and left ventricular pressure-volume rela-
tions has been the subject of debate, a general consensus is that
during inspiration the fall in intrathoracic pressure results in
increased filling of the right heart with increased right ventric-
ular stroke volume. The increased pleural pressure increases
left ventricular afterload and together with the increased right
ventricular volume result in reduced stroke volume during
inspiration (17, 24, 26, 41, 49). In RR interval studies, it has
been shown that the influence of SBP variability on RR
variability was high during rest (36–39). The methodology
used in this work did not reveal a strong causal interaction from
SBP to ARI respiratory oscillations (Fig. 6). This should be
interpreted within the limit of a linear model and does not
exclude a more complex involvement of blood pressure in the
generation ARI oscillation. For example, a change in intraven-
tricular pressure may induce regional changes in cardiac strain
that could in turn cause ARI oscillations via the mechano-
electric feedback pathway (44, 46). Therefore, blood pressure
changes, which only partially reveals heterogeneous cardiac
strain, may be involved in the generation of ARI oscillations
without necessarily exhibiting a linear interaction with them.
Another possible mechanism is central gating of autonomic
neural traffic by central respiratory networks (15), arising as a
result of brainstem interactions (6) or entrained by cortical
activity during controlled breathing (10). We could not exclude
the possibility that the cardioselective -adrenergic blocking
agent metoprolol we used, being moderately lipophilic and
therefore capable of passing the blood brain barrier, could have
exerted a central effect.
Parasympathetic activity decreases during inspiration and,
therefore, could potentially influence APD by the ACh-acti-
vated K
 current IK, ACh, now recognized as being widely
represented in ventricular myocardium (7). In the present study
the administration of atropine after -blockade induced no
further effect on the amplitude of the ARI oscillations, sug-
gesting no significant involvement of this current.
The -adrenergic signaling cascade involves phosphoryla-
tion of a number of target proteins, and it is at present unclear
as to whether the time constants of the phosphorylation/de-
phosphorylation process would be capable of following the
breathing frequencies used in the present study. An alternative
possibility is that sympathetic activity may act indirectly by
interacting by modulating mechano-electric coupling (MEC).
MEC whereby changes in myocardial fiber stretch/strain
alter the electrophysiology (29, 44, 46) has been shown to be
substantially enhanced by -adrenergic blocking agents (22),
and therefore the reduction in the oscillation of APD that we
Fig. 4. Mean values of peak-to-peak amplitude of respiratory-related oscilla-
tions of ARI and SBP during control (C), following administration of -ad-
renergic blocking (BB) agents and after subsequent addition of atropine (AT

BB). After administration of -blockers, the amplitude of LV ARI and SBP
oscillations were significantly reduced, and a trend to reduction was seen for
RV ARI oscillations. *P  0.05; **P  0.01.
H2113ADRENERGIC BLOCKADE AND APD OSCILLATIONS
AJP-Heart Circ Physiol • doi:10.1152/ajpheart.00560.2015 • www.ajpheart.org
observed after administration of metoprolol would be consis-
tent with MEC as an underlying mechanism. The effects of
MEC on APD are complex depending on the nature and timing
of the mechanical perturbation (3, 27, 42, 47). In general
increased stretch tends to shorten APD. Increased fiber length
increases the affinity of Troponic C for calcium, which slows
calcium release from TnC resulting in a reduced calcium
transient, decreased NaCa exchange current, and APD short-
ening. Increased fiber shortening results in a decreased affinity
of TnC for calcium, faster calcium release, an increased cal-
cium transient, increased inward NaCaX, and APD prolonga-
tion. In addition stretch-activated channels either shorten or
lengthen APD dependent on the timing of the stretch relative to
the reversal potential ( 30 mv), such that early stretch
shortens and late stretch lengthens APD. Thus the overall
effect is likely to be a complex function of whichever mech-
anism is dominant. As described above, during inspiration LV
stroke volume decreases, which would be expected to reduce
stretch and fiber excursion, whereas opposite effects would be
expected in the RV. The marked variability that we observed in
phase of ARI oscillations that we observed between endocar-
dial left ventricular free wall and right ventricular septum
would be consistent with such a mechanism. Discordant ARI
oscillations in the LV and RV increased the regional ARI
differences between LV and RV. We observed that the disper-
sion of ARI (APD) between left and right ventricle could
increase up to 40 ms when ARI oscillations reached their
peak in the RV and its trough in the LV at the same time.
Because ARI is a component of total repolarization and re-
gional differences in repolarization are important in arrhyth-
mias based on reentry, the cyclical variation in dispersion of
ARI due to respiration may contribute to the conditions for
reentry to occur.
Conclusion
The dynamics of ventricular repolarization play a critical
role in maintaining electrical stability. We have investigated
the role of the autonomic nervous system in generating oscil-
lations in ventricular APD at the respiratory frequency in
humans with healthy ventricles. Ventricular APD and SBP
exhibited oscillations at each of four controlled respiratory
frequencies. The -adrenergic blocking agent metoprolol
partly but not completely reduced the APD oscillation. The
addition of a parasympathetic blocking agent (atropine) was
without any additional effect. Directed coherence as a measure
of causality indicated respiration rather than (femoral artery)
SBP as a major cause of APD oscillation. -Adrenergic block-
ade reduced the contribution of respiration to APD oscillations.
The results are consistent with a role of the sympathetic
nervous system combined with an additional mechanism.
APPENDIX A: MULTIVARIATE AUTOREGRESSIVE MODEL
In this study, ARI, SBP, and RESP are a joint multivariate zero-
mean process: Y(n)  [yARI(n), ySBP(n), yRESP(n)] T. Here, ARI is
numbered as process 1, SBP is process 2, and RESP is process 3. The
set was described as a multivariate autoregressive (MVAR) process
defined as:
Yn
k1
p
AkYn k Un
where p is the model order, A(k), k  1, , p, are the 33 matrices
containing the coefficients aij(k) that describe the linear interaction at
lag k from yj(n-k) to yi(n) (i,j  1,2,3), and U(n)  [u1(n), u2(n),
u3(n)]T is a vector of zero-mean white noise processes with diagonal
covariance matrix U. This strictly causal model representation (k0)
cannot describe zero-delay correlations among the observed series Y,
which are thus explained by correlations among the input noises U. To
overcome this problem, series Y can be described including instanta-
neous effects [yi(n) to yj(n)] into the interactions allowed by the model
as proposed by Faes and Nollo (12). This is achieved by extending the
MVAR process:
Yn
k0
p
BkYn kWn
Like U(n), W(n)  [w1(n), w2(n), w3(n)]T is a vector of uncorre-
lated processes with diagonal covariance matrix W. Instantaneous
Fig. 5. Mean coherence measures the cou-
pling strength between ARI and respiration
(left), between SBP and RESP (middle), and
between ARI and SBP (right). Significant
coherence was detected in all subjects and
was unaffected after administration of auto-
nomic blocking agents.
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effects are modelled in the form of the coefficients bij(0) of the matrix
B(0). B(0) is a lower triangular matrix with null diagonal and can only
be solved by imposing a priori knowledge of the structure of instan-
taneous causation, i.e., the time-series have to be ordered in a way that
instantaneous effects are allowed from one process to another but not
vice versa. The instantaneous effects were ordered based on informa-
tion of the physiological system: respiration was measured before ARI
and before SBP due to the pulse transit time and the time delay
between electrical and mechanical activation.
APPENDIX B: DEFINITIONS OF SPECTRA, COHERENCE, AND
DIRECTED COHERENCE FOR MVAR MODELS
The spectral representation of the MVAR process is derived con-
sidering the Fourier transform of the MVAR process:
Y f B fY fW f
The transfer function that links input and output is the inverse of
the coefficients of B:
Fig. 6. Assessment of the causal interactions
between respiration (RESP), ARI, and SBP.
A: possible (theoretical) interactive path-
ways between all processes. B: for all pro-
cesses the mean relative power contributions
related to all processes (the directed coher-
ence) at the breathing frequency. Black
quantifies the contribution of respiration;
densely hatched represents SBP and lightly
hatched ARI. The directed coherence was
measured during control (C), following ad-
ministration of -adrenergic blocking (BB),
and subsequent addition of atropine (BB 

AT). For example, during control, the di-
rected coherence from respiration to ARI
(left) is 0.70, indicating that respiration ex-
plains 70% of ARI signal power at the
breathing frequency. Administration of
-blocker agents significantly reduced the
contribution of respiration to respiratory-re-
lated oscillations of activation recovery in-
tervals (P  0.05).
Fig. 7. Two examples of oscillations in the RV and LV. Right:
example in which both oscillations are approximately in phase.
Left: example in which the oscillations are approximately in
anti-phase. Note the different time scales for clarity.
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H f I B f1
where I is the identity matrix. The spectral matrix is then defined as:
S f H f  HH f
where the superscript H stands for the Hermitian transpose and 
is the covariance matrix. Its compact form is written as:
Sij f hi f  hj f
Under the assumption that the input white noises are uncorrelated,
their covariance matrix  reduced to the diagonal matrix   diag
i
2, where i
2 is the variance of wi.
S can be factorized in:
Sij f 
m 1
3
m
2 Him fHjm  f
The coherence between yi and yj is defined as:
ϒij f
Sij f
	Sii fSjj f
ϒij f
hi f hjH f
	hi f hiH f	hj f hjH f
 
m 1
3 mHim f
	Sii f
mHjm
  f
	Sjj f
 
m 1
3
im f jm  f
The last term contains the so-called directed coherence. The di-
rected coherence () from yi to yj is defined as:
ij f
 jHij f
	m 13 m2 Him f2
APPENDIX C: METHODOLOGICAL CONSIDERATIONS FOR
FREQUENCY DOMAIN MEASURES OF CAUSALITY
For this study, respiration was required to be voluntarily controlled,
and the tidal change voluntarily adjusted to suit the wide range of
rates, thus avoiding hyper- or hypoventilation. By controlling the
respiratory frequency, we endeavored to maximize stationarity of
respiratory modulation of APD. Estimation of the amplitude using the
power spectra are, therefore, likely to have produced the average
frequency content of the ARI and SBP signal over the entire recording
time of 90 s. To provide a good representation of the frequency
content, Thomson’s multitaper spectra were used to estimate the
amplitude of ARI and SBP oscillations. When compared with the
Fourier Transform, this method reduces the amplitude estimation bias
by obtaining multiple estimates from the same sample and averaging
over all the tapered spectra (48). The cyclical variation of ARI and
SBP was quantified as peak-to-peak amplitude, since this measure
represents the absolute changes in APD.
Frequency domain measures of causality have been used previ-
ously to investigate causal interactions between spontaneous variabil-
ity of the heart period (RR interval), SBP, and the respiratory flow (36,
39). To the best of our knowledge, our work is the first application in
studying cardiorespiratory interactions between ventricular endocar-
dial APD, SBP, and RESP. In this work, we used a MVAR model that
describes both lagged and instantaneous effects as proposed by Faes
and colleagues (12, 38, 39). The use of a strictly causal MVAR
models to describe multiple time series with zero-lag correlations may
lead to incorrect estimates of the lagged effects and thus to erroneous
causality inferences.
MEC is the process by which mechanical forces on the myocar-
dium can alter its electrical properties (3, 27, 29, 42, 47). In contrast
with the baroreceptor reflex, MEC may act almost instantaneously
(i.e., before arrival of the next heart beat). Consequently, to achieve a
full description of the correlation structure of the observed signals, we
used an extended MVAR model that combines both instantaneous and
lagged effects. When neglecting instantaneous effects, we discovered
cross-correlation between the residuals, indicating that causality mea-
sures would have been adversely affected when excluding instanta-
neous effects (12, 13). The analysis showed that the directed coher-
ence from ARI to RESP and from SBP to RESP was (very) low,
which corresponds to our expectations, since these pathways do not
have any physiological meaning. With respect to nonparametric meth-
ods, MVAR analysis presents the advantage of infer directionality and
causality through the parameterization of the mutual interactions
between processes (37).
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